相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RUNX represses Pmp22 to drive neurofibromagenesis
Ashley Hall et al.
SCIENCE ADVANCES (2019)
The CDK inhibitor p21 is a novel target gene of ATF4 and contributes to cell survival under ER stress
Yasumichi Inoue et al.
FEBS LETTERS (2017)
CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis
G. Cordonnier et al.
LEUKEMIA (2017)
An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system
Kwangmin Choi et al.
SCIENTIFIC REPORTS (2017)
Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy
Eslam Mohamed et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Endoplasmic reticulum proteostasis: a key checkpoint in cancer
Scott A. Oakes
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)
Neurofibromatosis type 1 and malignancy in childhood
A. Varan et al.
CLINICAL GENETICS (2016)
Runx1 contributes to neurofibromatosis type 1 neurofibroma formation
H. Li et al.
ONCOGENE (2016)
Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse
Mariapaola Sidoli et al.
JOURNAL OF NEUROSCIENCE (2016)
Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation
Jianqiang Wu et al.
CELL REPORTS (2016)
The Role of Endoplasmic Reticulum Stress in Human Pathology
Scott A. Oakes et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 10 (2015)
Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells
Xiongwei Cai et al.
CELL STEM CELL (2015)
Proteostasis control by the unfolded protein response
Claudio Hetz et al.
NATURE CELL BIOLOGY (2015)
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor
Nancy Ratner et al.
NATURE REVIEWS CANCER (2015)
Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy
Raymond J. Deshaies
BMC BIOLOGY (2014)
The Splicing Factor RBM4 Controls Apoptosis, Proliferation, and Migration to Suppress Tumor Progression
Yang Wang et al.
CANCER CELL (2014)
MLL3 Is a Haploinsufficient 7q Tumor Suppressor in Acute Myeloid Leukemia
Chong Chen et al.
CANCER CELL (2014)
Endoplasmic Reticulum Stress in Malignancy
Hanna J. Clarke et al.
CANCER CELL (2014)
Aneuploidy: implications for protein homeostasis and disease
Ana B. Oromendia et al.
DISEASE MODELS & MECHANISMS (2014)
Oncogenic Activation of MEK/ERK Primes Melanoma Cells for Adaptation to Endoplasmic Reticulum Stress
Amanda Croft et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Epithelial-to-Mesenchymal Transition Activates PERK-eIF2α and Sensitizes Cells to Endoplasmic Reticulum Stress
Yu-xiong Feng et al.
CANCER DISCOVERY (2014)
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors
Walter J. Jessen et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
p58IPK-Mediated Attenuation of the Proapoptotic PERK-CHOP Pathway Allows Malignant Progression upon Low Glucose
Anne-Laure Huber et al.
MOLECULAR CELL (2013)
Hypoxia stimulates migration of breast cancer cells via the PERK/ATF4/LAMP3-arm of the unfolded protein response
Anika Nagelkerke et al.
BREAST CANCER RESEARCH (2013)
Nuclear export of proteins and drug resistance in cancer
Joel G. Turner et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK)
Jeffrey M. Axten et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors
Thomas De Raedt et al.
CANCER CELL (2011)
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer
Roelof Koster et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
E. Bobrovnikova-Marjon et al.
ONCOGENE (2010)
Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene
Shyra J. Miller et al.
EMBO MOLECULAR MEDICINE (2009)
Neurofibromatosis type 1
Kevin P. Boyd et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells
Jianqiang Wu et al.
CANCER CELL (2008)
Nf1 Mutation Expands an EGFR-Dependent Peripheral Nerve Progenitor that Confers Neurofibroma Tumorigenic Potential
Jon P. Williams et al.
CELL STEM CELL (2008)
Adapting proteostasis for disease intervention
William E. Balch et al.
SCIENCE (2008)
Improved human β-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element
Paritha I. Arumugam et al.
MOLECULAR THERAPY (2007)
Tumor microenvironment and neurofibromatosis type I: connecting the GAPs
L. Q. Le et al.
ONCOGENE (2007)
A negative feedback signaling network underlies oncogene-induced senescence
Stephanie Courtois-Cox et al.
CANCER CELL (2006)
ER chaperone functions during normal and stress conditions
YJ Ma et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2004)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Neurofibromas in NF1: Schwann cell origin and role of tumor environment
Y Zhu et al.
SCIENCE (2002)
CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein survivin
JA Rodríguez et al.
EXPERIMENTAL CELL RESEARCH (2002)
Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain
Y Zhu et al.
GENES & DEVELOPMENT (2001)
Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells
BHP Zhou et al.
NATURE CELL BIOLOGY (2001)
分享论文
